Literature DB >> 33153807

Therapeutic Ultrasound Parameter Optimization for Drug Delivery Applied to a Murine Model of Hepatocellular Carcinoma.

Arsenii V Telichko1, Huaijun Wang1, Sunitha Bachawal1, Sukumar U Kumar1, Jagathesh C Bose1, Ramasamy Paulmurugan1, Jeremy J Dahl2.   

Abstract

Ultrasound and microbubble (USMB)-mediated drug delivery is a valuable tool for increasing the efficiency of the delivery of therapeutic agents to cancer while maintaining low systemic toxicity. Typically, selection of USMB drug delivery parameters used in current research settings are either based on previous studies described in the literature or optimized using tissue-mimicking phantoms. However, phantoms rarely mimic in vivo tumor environments, and the selection of parameters should be based on the application or experiment. In the following study, we optimized the therapeutic parameters of the ultrasound drug delivery system to achieve the most efficient in vivo drug delivery using fluorescent semiconducting polymer nanoparticles as a model nanocarrier. We illustrate that voltage, pulse repetition frequency and treatment time (i.e., number of ultrasound pulses per therapy area) delivered to the tumor can successfully be optimized in vivo to ensure effective delivery of the semiconducting polymer nanoparticles to models of hepatocellular carcinoma. The optimal in vivo parameters for USMB drug delivery in this study were 70 V (peak negative pressure = 3.4 MPa, mechanical index = 1.22), 1-Hz pulse repetition frequency and 100-s therapy time. USMB-mediated drug delivery using in vivo optimized ultrasound parameters caused an up to 2.2-fold (p < 0.01) increase in drug delivery to solid tumors compared with that using phantom-optimized ultrasound parameters.
Copyright © 2020 World Federation for Ultrasound in Medicine & Biology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Drug delivery; Hepatocellular carcinoma; Microbubbles; Sonoporation; Therapy; Ultrasound

Mesh:

Year:  2020        PMID: 33153807      PMCID: PMC8489309          DOI: 10.1016/j.ultrasmedbio.2020.09.009

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  51 in total

1.  Transfection of a reporter plasmid into cultured cells by sonoporation in vitro.

Authors:  S Bao; B D Thrall; D L Miller
Journal:  Ultrasound Med Biol       Date:  1997       Impact factor: 2.998

2.  Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs.

Authors:  Tommaso Di Ianni; Rajendran J C Bose; Uday K Sukumar; Sunitha Bachawal; Huaijun Wang; Arsenii Telichko; Carl Herickhoff; Elise Robinson; Sam Baker; José G Vilches-Moure; Stephen A Felt; Sanjiv S Gambhir; Ramasamy Paulmurugan; Jeremy D Dahl
Journal:  J Control Release       Date:  2019-07-18       Impact factor: 9.776

3.  Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma.

Authors:  Yoshito Tomimaru; Hidetoshi Eguchi; Hiroaki Nagano; Hiroshi Wada; Shogo Kobayashi; Shigeru Marubashi; Masahiro Tanemura; Akira Tomokuni; Ichiro Takemasa; Koji Umeshita; Tatsuya Kanto; Yuichiro Doki; Masaki Mori
Journal:  J Hepatol       Date:  2011-07-13       Impact factor: 25.083

Review 4.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors:  Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 5.  Resection and liver transplantation for hepatocellular carcinoma.

Authors:  Josep M Llovet; Myron Schwartz; Vincenzo Mazzaferro
Journal:  Semin Liver Dis       Date:  2005       Impact factor: 6.115

6.  Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients.

Authors:  H Bismuth; L Chiche; R Adam; D Castaing; T Diamond; A Dennison
Journal:  Ann Surg       Date:  1993-08       Impact factor: 12.969

Review 7.  Gene therapy of hepatocarcinoma: a long way from the concept to the therapeutical impact.

Authors:  René Gérolami; Rathviro Uch; Christian Bréchot; Patrice Mannoni; Claude Bagnis
Journal:  Cancer Gene Ther       Date:  2003-09       Impact factor: 5.987

Review 8.  Epidemiology of hepatocellular carcinoma: consider the population.

Authors:  Sahil Mittal; Hashem B El-Serag
Journal:  J Clin Gastroenterol       Date:  2013-07       Impact factor: 3.062

9.  Effects of Low Intensity Focused Ultrasound on Liposomes Containing Channel proteins.

Authors:  Meghedi Babakhanian; Limin Yang; Bryan Nowroozi; George Saddik; Lilian Boodaghians; Paul Blount; Warren Grundfest
Journal:  Sci Rep       Date:  2018-11-22       Impact factor: 4.996

10.  Ultrasonic enhancement of drug penetration in solid tumors.

Authors:  Chun-Yen Lai; Brett Z Fite; Katherine W Ferrara
Journal:  Front Oncol       Date:  2013-08-19       Impact factor: 6.244

View more
  4 in total

1.  Enhancing carrier flux for efficient drug delivery in cancer tissues.

Authors:  Andrés Arango-Restrepo; J Miguel Rubi; Signe Kjelstrup; Bjørn Atle J Angelsen; Catharina de Lange Davies
Journal:  Biophys J       Date:  2021-10-30       Impact factor: 4.033

2.  Engineered Cell-Derived Vesicles Displaying Targeting Peptide and Functionalized with Nanocarriers for Therapeutic microRNA Delivery to Triple-Negative Breast Cancer in Mice.

Authors:  Rajendran Jc Bose; Uday Sukumar Kumar; Fernando Garcia-Marques; Yitian Zeng; Frezghi Habte; Jason R McCarthy; Sharon Pitteri; Tarik F Massoud; Ramasamy Paulmurugan
Journal:  Adv Healthc Mater       Date:  2021-12-17       Impact factor: 9.933

3.  Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma.

Authors:  Huaijun Wang; Zhongqian Hu; Uday Kumar Sukumar; Rajendran Jc Bose; Arsenii Telichko; Jeremy J Dahl; Ramasamy Paulmurugan
Journal:  Nanotheranostics       Date:  2022-01-01

4.  Efficacy optimization of low frequency microbubble-mediated sonoporation as a drug delivery platform to cancer cells.

Authors:  Michal Eck; Ramona Aronovich; Tali Ilovitsh
Journal:  Int J Pharm X       Date:  2022-09-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.